Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose of Trelagliptin for Egyptian Patients Requires no Modification Than Japanese

NCT04374864 is registered in ClinicalTrials.gov with British University In Egypt as lead sponsor.

NCT NCT04374864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04374864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose of Trelagliptin for Egyptian Patients Requires no Modification Than Japanese
Lead sponsor
British University In Egypt
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2020
Completion date
July 1, 2020
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus